The prognostic impact of C‐reactive protein and albumin in patients diagnosed with acute myeloid leukaemia
Abstract Background Acute myeloid leukaemia (AML) is an aggressive and heterogeneous malignant disease. Patient age, comorbidities and disease‐specific genetic abnormalities are recognized as primary determinants of treatment response. Recent years have elucidated the significance of nutritional sta...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-12-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.1022 |